Trials / Completed
CompletedNCT00182507
Olanzapine in the Treatment of Hair Pulling (Trichotillomania)
A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 34 (planned)
- Sponsor
- Hamilton Health Sciences Corporation · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Trichotillomania (TTM) or hair-pulling has been considered as part of the obsessive compulsive disorder (OCD) spectrum, although treatment with OCD medications has largely been unsuccessful. Tics/Tourrettes' Syndrome (TS) is a disorder, which appears to be related to TTM, but is treated with a different class of medications than used in OCD, namely antipsychotics such as olanzapine. This is a study of the safety and efficacy of olanzapine in the treatment of hair pulling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olanzapine |
Timeline
- Start date
- 2000-06-01
- Completion
- 2006-03-01
- First posted
- 2005-09-16
- Last updated
- 2006-09-11
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00182507. Inclusion in this directory is not an endorsement.